Dendreon's Provenge gets FDA review date

Courtesy Newsvine - business  Fri, 11/20/2009 - 09:54

Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1.


 

Related items

Diet Treatment, Already in Use, to Get F.D.A. Review
The Food and Drug Administration will review a new diet pill consisting of a combination of two pills people are using in California to lose weight.

Mead Johnson Says Its Tests Show Enfamil Baby Formula...
Mead Johnson Nutrition Co. said tests it conducted on samples of its Enfamil baby formula tied to an U.S. Food and Drug Administration investigation found no presence of bacteria.

Retiring Amgen CEO Kevin Sharer to Hand Role to...
Kevin Sharer, who has run Amgen Inc., the world's largest biotechnology company, for the past decade, will hand the reins to Robert Bradway, president and chief operating officer, in May.

Samsung SCX-4200 3-in-1 True Multifunction Printer
The SCX-4200 Digital Productivity Center is a low cost black and white laser printer, delivering 3 in 1 true multifunction performance with professional laser output.Keep your valuable real...

BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
The X5 Stereo Bluetooth Headset is a portable multi-function device utilizing the latest cutting edge technologies allowing you to stream high quality music and make voice calls using a...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com